Wells Fargo & Company Moderna, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Moderna, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 320,521 shares of MRNA stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

320,521

Previous 416,480 23.04%

Holding current value

$13.2 Million

Previous $49.5 Million 56.69%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $6.11 Million - $12 Million	-95,959 Reduced 23.04%	320,521 $21.4 Million
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $14.5 Million - $23.8 Million	142,980 Added 52.28%	416,480 $49.5 Million
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $1.09 Million - $1.48 Million	12,822 Added 4.92%	273,500 $29.1 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $2.96 Million - $4.44 Million	-42,533 Reduced 14.03%	260,678 $25.9 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $1.37 Million - $1.8 Million	-14,210 Reduced 4.48%	303,211 $31.3 Million
Q2 2023 Aug 15, 2023	SELL	$118.5 - $160.53 $2.39 Million - $3.23 Million	-20,138 Reduced 5.97%	317,421 $38.6 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $2.71 Million - $3.93 Million	19,953 Added 6.28%	337,559 $51.8 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $4.2 Million - $7.44 Million	-35,437 Reduced 10.04%	317,606 $57 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $1.15 Million - $1.9 Million	-9,780 Reduced 2.7%	353,043 $41.7 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $7.82 Million - $11.8 Million	-66,786 Reduced 15.55%	362,823 $51.8 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $5 Million - $9.29 Million	-39,521 Reduced 8.42%	429,609 $74 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $22.9 Million - $37.3 Million	-101,312 Reduced 17.76%	469,130 $119 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $43.3 Million - $94.5 Million	195,101 Added 51.98%	570,442 $220 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.09 Million - $1.97 Million	-8,383 Reduced 2.18%	375,341 $88.2 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $3.71 Million - $6.32 Million	-33,989 Reduced 8.14%	383,724 $50.2 Million
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $10.6 Million - $27.3 Million	160,677 Added 62.51%	417,713 $43.6 Million
Q3 2020 Nov 05, 2020	BUY	$54.34 - $94.85 $133,676 - $233,331	2,460 Added 0.97%	257,036 $18.2 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $2.99 Million - $8.06 Million	100,760 Added 65.51%	254,576 $16.3 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $2.73 Million - $4.86 Million	153,816 New	153,816 $4.61 Million

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Moderna, Inc. Transaction History